Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Other Non Operating Income (2024 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Other Non Operating Income for 4 consecutive years, with $1.8 million as the latest value for Q2 2025.

  • On a quarterly basis, Other Non Operating Income fell 55.66% to $1.8 million in Q2 2025 year-over-year; TTM through Jun 2025 was $6.1 million, a 43.3% increase, with the full-year FY2011 number at $153000.0, up 103.8% from a year prior.
  • Other Non Operating Income was $1.8 million for Q2 2025 at Lexicon Pharmaceuticals, down from $4.1 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $4.1 million in Q2 2024 to a low of $1.8 million in Q2 2025.